Pharming Group N.V. (AMS: PHARM)

Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Cash & Equivalents	60.66	61.74	207.34	191.92	205.16	74.35
Short-Term Investments	111.1	151.68	-	-	-	-
Cash & Short-Term Investments	171.77	213.42	207.34	191.92	205.16	74.35
Cash Growth	-13.06%	2.93%	8.03%	-6.45%	175.94%	-7.42%
Accounts Receivable	48.2	35.41	20.96	18.08	23.51	28.86
Other Receivables	-	7.21	4.37	9.52	8.37	-
Receivables	48.2	42.62	25.33	27.59	31.88	28.86
Inventory	62.23	56.76	42.33	27.31	21.16	16.22
Prepaid Expenses	-	3.54	2.29	2.39	4.02	-
Restricted Cash	-	-	0.21	0.23	1	-
Total Current Assets	282.19	316.34	277.5	249.44	263.21	119.44
Property, Plant & Equipment	30.67	33.47	39.15	33.17	21.65	16.3
Long-Term Investments	7.17	10.4	9.73	8.65	7.12	6.18
Other Intangible Assets	67.1	71.27	74.87	83.57	88.63	74.58
Long-Term Deferred Tax Assets	36.75	29.76	22.97	21.22	31.88	32.06
Long-Term Deferred Charges	-	-	0.25	0.27	5.46	4.83
Other Long-Term Assets	1.64	1.62	1.33	1.01	0.51	2.54
Total Assets	425.51	462.85	425.8	397.32	418.45	255.92
Accounts Payable	72.64	16.02	8.75	7.6	13.47	40.65
Accrued Expenses	-	50.27	43.61	33.34	33.4	-
Current Portion of Long-Term Debt	3.32	1.82	1.77	1.88	2.04	51.13
Current Portion of Leases	3.88	3.62	3.47	2.42	1.96	2.18
Current Income Taxes Payable	-	6.23	2.1	1.51	0.62	-
Other Current Liabilities	-	-	-	0.03	25.36	20.3
Total Current Liabilities	79.84	77.97	59.7	46.77	76.85	114.25
Long-Term Debt	92.1	136.6	131.62	139.01	149.73	-
Long-Term Leases	27.78	29.51	29.84	18.46	8.23	4.89
Other Long-Term Liabilities	-	-	-	0.17	0.21	19.38
Total Liabilities	199.72	244.07	221.16	204.4	235.02	138.53
Common Stock	7.75	7.67	7.51	7.43	7.31	7.23
Additional Paid-In Capital	487.08	478.43	462.3	455.25	447.13	441.95
Retained Earnings	-269.04	-267.32	-265.17	-269.77	-271.01	-331.79
Shareholders' Equity	225.79	218.78	204.64	192.92	183.44	117.39
Total Liabilities & Equity	425.51	462.85	425.8	397.32	418.45	255.92
Total Debt	127.08	171.55	166.69	161.76	161.96	58.2
Net Cash (Debt)	44.68	41.88	40.65	30.16	43.2	16.15
Net Cash Growth	33.06%	3.03%	34.76%	-30.18%	167.53%	118.75%
Net Cash Per Share	0.07	0.06	0.06	0.04	0.06	0.02
Filing Date Shares Outstanding	517	673.44	656.35	648.75	641.29	634.99
Total Common Shares Outstanding	517	671.07	656.35	648.75	638.82	631.32
Working Capital	202.35	238.37	217.8	202.67	186.36	5.18
Book Value Per Share	0.44	0.33	0.31	0.30	0.29	0.19
Tangible Book Value	158.7	147.51	129.77	109.35	94.81	42.81
Tangible Book Value Per Share	0.31	0.22	0.20	0.17	0.15	0.07
Land	-	-	-	0.03	0.03	0.03
Machinery	-	9.66	8.28	14.84	6.59	5.9
Construction In Progress	-	0.18	0.01	0.62	2.87	0.34
Leasehold Improvements	-	5.55	5.28	5.71	2.48	2.22

Source: S&P Capital IQ. Standard template. Financial Sources.